Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077

Studies in human immunodeficiency virus (HIV)–infected individuals suggest excess weight gain with integrase inhibitor–based antiretroviral therapy. The HIV Prevention Trials Network Study 077 evaluated changes in weight and fasting metabolic parameters in HIV-uninfected individuals randomized to ca...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Infect Dis
Asıl Yazarlar: Landovitz, Raphael J, Zangeneh, Sahar Z, Chau, Gordon, Grinsztejn, Beatriz, Eron, Joseph J, Dawood, Halima, Magnus, Manya, Liu, Albert Y, Panchia, Ravindre, Hosseinipour, Mina C, Kofron, Ryan, Margolis, David A, Rinehart, Alex, Adeyeye, Adeola, Burns, David, McCauley, Marybeth, Cohen, Myron S, Currier, Judith S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6938971/
https://ncbi.nlm.nih.gov/pubmed/31125395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz439
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller